FindTrial
Sign In

Multicenter, double-blind randomized, controlled study for the treatment of involutional osteoporosis

Multicenter, double-blind randomized, controlled study for the treatment of involutional osteoporosis

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220084
Enrollment
Unknown
Registered
2005-09-12
Start date
2005-09-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Involutional osteoporosis

Interventions

investigational material(s) Generic name etc : ONO-5920 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigati

Sponsors

ONO PHARMACEUTICAL CO.,LTD.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients of female aged 55 years or older and under 81 years with documented involutional osteoporosis with prevalent fracture according to the diagnostic criteria for primaly osteoporosis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy, Safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026